Exactech Launches Gibralt® OCT Spinal System for Complex Cervical Thoracic Spine Procedures Now Offe
Exactech Launches Gibralt®OCT Spinal System for Complex Cervical Thoracic Spine Procedures
Now Offering Spinal Fusion Solutions For The Entire Spine
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (NAS: EXAC) , which designs and manufactures bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, said that its Exactech Spine division has received FDA clearance of its new Gibralt® Occipital Spine System, which includes occipital plates and 360⁰ articulating rods.
With these additions, Exactech now provides spinal fusion solutions for the full spine from the occiput, or the back portion of the skull, to the sacrum, the bone at the base of the spine. Posterior cervical spinal fusion procedures continue to increase globally, with an estimated 100,000 procedures to be performed in the United States in 2013. This type of procedure uses various components that act as an internal brace to provide stabilization during fusion.
The Gibralt OCT system includes polyaxial screws and cannulated screws in multiple diameters and lengths, hooks, rods, rod-to-rod connectors, offset connectors and cross connectors to provide maximum versatility for the surgeon.
The occipital plate features medial lateral adaptability from 25-45mm, bend zones for easy contouring, low-profile occipital screws and 360⁰ articulating rods that offer flexibility in positioning. Clinicians may construct Gibralt Spinal System components into a multitude of configurations based on individual patient anatomy.
"We are excited to release the final components of the Gibralt System to the market," said Bruce Thompson, Exactech Senior Vice President and Spine Division General Manager. "The occipital plate and articulating rods provide surgeons with a comprehensive posterior solution. The Gibralt OCT system provides seamless integration with the Proliant 5.5mm and Hydralok 6.0mm Thoraco-Lumbar Pedicle Screw Systems."
Exactech officials report that the initial launch of the complete Gibralt system is under way in the United States.
Surgeons who want to learn more about the recently expanded scope and the latest techniques in spinal surgery can take advantage of Exactech's personalized medical education programs. Clinicians can design the workshop that best meets their individual preferences including live surgery observation, cadaveric courses, hospital in-service programs or in-depth technical design review with Exactech product management and engineering staff at the corporate headquarters in Gainesville, Fla.
About Exactech Spine and the Gibralt Spinal System
Offering exceptional versatility and ease-of-use, the Gibralt Spinal System features top-loading polyaxial screws with the unique EZ Set® Polyaxial Tulip Head, hooks, offset connectors and rod-to-rod connectors which can be constructed into many different configurations based on each patient's anatomy.
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech's orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 35 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech's press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.
An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company's expectations or beliefs concerning future events of the company's financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company's dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company's products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
1A. Macario. "What does one minute of operating room time cost?," Journal of Clinical Anesthesia, vol. 22, no. 4, pp. 233-236, Jun. 2010.
2Computer Assessment of Scapula Cortical and Cancellous Bone Removal When Correcting a Posterior Defect Using Three Different Glenoid Prosthesis Desings Trans. of the 59th Annual ORS Meeting. 2013.
3Reference on file.
4Data on file at Exactech. 051K. Intercondylar Femoral Notch Preparation for Posterior Stabilized Knee Arthroplasty - Volumetric Bone Resection According to Two Methods.
Jody Phillips, 352-377-1140
Chief Financial Officer
Julie Marshall or Frank Hawkins, 305-451-1888
Priscilla Bennett, 352-377-1140
Director Marketing Communication & Public Relations
KEYWORDS: United States North America Florida
The article Exactech Launches Gibralt® OCT Spinal System for Complex Cervical Thoracic Spine Procedures Now Offering Spinal Fusion Solutions For The Entire Spine originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.